- CONTACT US
- AFS
- Business
- Bussiness
- Car
- Career
- Celebrity
- Digital Products
- Education
- Entertainment
- Fashion
- Film
- Food
- Fun
- Games
- General Health
- Health
- Health Awareness
- Healthy
- Healthy Lifestyle
- History Facts
- Household Appliances
- Internet
- Investment
- Law
- Lifestyle
- Loans&Mortgages
- Luxury Life Style
- movie
- Music
- Nature
- News
- Opinion
- Pet
- Plant
- Politics
- Recommends
- Science
- Self-care
- services
- Smart Phone
- Sports
- Style
- Technology
- tire
- Travel
- US
- World

Dec 3 (Reuters) - Lockheed Martin said on Wednesday it has opened a hypersonics system integration lab at its Huntsville campus as it pushes to develop next-generation weapons.
Hypersonic weapons, which can travel at more than five times the speed of sound and evade traditional defenses, are at the centre of an arms race between the United States and China.
Lockheed's 17,000-square-foot facility will include advanced test equipment, simulation tools and an integration environment.
It is part of a larger capital program that now totals roughly $529 million and includes 719,000 square feet of facilities under construction or planned, the company said.
"Hypersonic weapons are reshaping the future of military defense by delivering unmatched speed and maneuverability that outpace traditional threats," said Holly Molmer, program management director for Lockheed Martin
In October, defense start-up Castelion said it won contracts to integrate its Blackbeard hypersonic strike weapon with current U.S. Army systems.
(Reporting by Aishwarya Jain in Bengaluru; Editing by Shailesh Kuber)
LATEST POSTS
- 1
Let them eat (Taylor Swift) cake: The baker turning A-listers into life-size desserts - 2
King Charles shares cancer treatment update, says it's a 'personal blessing' - 3
Early diagnosis leads King Charles to scale back cancer treatment in the new year - 4
Mont Blanc road tunnel reopens to traffic after 15 weeks of repairs - 5
Bavarian leader questions Germany's Eurovision participation
AstraZeneca to invest $2 billion as part of US manufacturing push
Analysis-From 'Icarus bug' to flawed panels: Airbus counts cost of relying on single model
CVS forecasts 2026 profit above estimates on strong performance
FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
Emergent Cold LatAm opens state-of-the-art cold storage hub in Guadalajara
US FDA panel to weigh bid to market nicotine pouches as lower-risk than cigarettes
Merck sees over $5 billion opportunity in Cidara's experimental flu drug
China's 1st reusable rocket explodes in dramatic fireball during landing after reaching orbit on debut flight
US FDA approves Kura-Kyowa's blood cancer therapy













